REMUS PHARMACEUTICALS
Smallcap | NSE
Sector
Here's the live share price of Remus Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.09₹ 18.40
As on Aug 14, 2026, 03:59 PM IST
Source: Dion Global
Remus Pharmaceuticals Price Performance
Today's LowToday's High
₹892.00₹917.95
₹897.35
52 Weeks' Low52 Weeks' High
₹580.00₹952.00
₹897.35
Open Price
₹896.95
Prev. Close
₹878.95
Volume
30,900
Source: Dion Global
Remus Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Remus Pharmaceuticals | 6.54 | 25.00 | 24.45 | 37.29 | 1.54 | 15.95 | 31.92 |
| Sun Pharmaceutical Industries | -0.77 | -0.65 | 3.59 | 13.50 | 17.58 | 19.38 | 19.84 |
| Divi's Laboratories | 2.44 | 17.92 | 22.47 | 37.85 | 38.23 | 31.47 | 11.59 |
| Torrent Pharmaceuticals | -1.85 | -2.82 | 9.74 | 13.41 | 33.40 | 34.83 | 26.75 |
| Cipla | -0.94 | 0.83 | 0.93 | 6.90 | -7.29 | 5.48 | 10.30 |
| Zydus Lifesciences | 1.88 | 0.14 | 14.47 | 24.69 | 14.81 | 20.95 | 16.37 |
| Lupin | -5.44 | -9.48 | -1.03 | 0.61 | 13.94 | 27.36 | 18.23 |
| Dr. Reddy's Laboratories | 2.39 | -3.71 | -7.95 | -5.47 | -4.79 | 1.00 | 5.18 |
| Mankind Pharma | -1.25 | -4.18 | -1.50 | 16.41 | -1.92 | 10.05 | 11.26 |
| Laurus Labs | -3.09 | 14.52 | 35.86 | 76.53 | 107.90 | 66.86 | 20.99 |
| Aurobindo Pharma | -2.17 | 4.46 | 7.36 | 36.93 | 49.70 | 23.00 | 17.06 |
| Biocon | -2.19 | -4.64 | -0.48 | 9.64 | 16.08 | 17.88 | 2.59 |
| Glenmark Pharmaceuticals | 1.72 | 0.58 | -0.95 | 14.18 | 13.39 | 42.71 | 32.42 |
| Alkem Laboratories | -4.48 | -4.17 | -3.74 | -2.05 | 0.38 | 12.25 | 7.65 |
| Abbott India | -2.78 | -1.60 | -1.67 | 2.93 | -18.65 | 4.61 | 7.38 |
| Anthem Biosciences | 5.84 | 18.69 | 8.54 | 29.02 | 7.90 | 6.82 | 4.04 |
| Gland Pharma | 14.19 | 19.37 | 56.47 | 64.26 | 50.33 | 22.83 | -6.32 |
| Ajanta Pharma | 5.26 | 7.74 | 12.69 | 24.92 | 36.74 | 28.31 | 19.31 |
| GlaxoSmithKline Pharmaceuticals | 3.43 | 9.15 | 11.26 | 3.52 | -2.92 | 23.86 | 10.85 |
| Ipca Laboratories | -0.09 | -5.77 | 9.49 | 15.99 | 26.96 | 25.16 | 7.52 |
Source: Dion Global
Over the last one year, Remus Pharmaceuticals has gained 1.54% compared to peers like Sun Pharmaceutical Industries (17.58%), Divi's Laboratories (38.23%), Torrent Pharmaceuticals (33.40%). From a 5 year perspective, Remus Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (19.84%) and Divi's Laboratories (11.59%).
Remus Pharmaceuticals Financials
Source: Dion Global
Remus Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 836.28 | 830.41 |
| 10 | 794.28 | 805.24 |
| 20 | 760.32 | 780.34 |
| 50 | 754.49 | 757.24 |
| 100 | 724.42 | 740.18 |
| 200 | 709.64 | 752.28 |
Source: Dion Global
Remus Pharmaceuticals Share Holding Pattern
In the latest quarter, Remus Pharmaceuticals saw a rise in promoter holding to 71.88%, while DII stake increased to 0.83%, FII holding rose to 5.28%, and public shareholding moved down to 22.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Remus Pharmaceuticals Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Remus Pharmaceuticals fact sheet for more information
Source: Dion Global
About Remus Pharmaceuticals
Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 93.99 Cr. and Equity Capital is Rs. 11.78 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ahmedabad Gujarat 380054
- Contact
Source: Dion Global
Management
- Mr. Swapnil Jatinbhai ShahChairman&Non WholeTimeDirector
- Mr. Arpit Deepakkumar ShahManaging Director
- Ms. Roma Vinodbhai ShahWhole Time Director
- Mrs. Anar Swapnil ShahNon Exe.Non Ind.Director
- Mr. Balwant PurohitInd. Non-Executive Director
- Mrs. Sanjana Sanjeev ShahInd. Non-Executive Director
- Mr. Vishrut Chandramauli PathakInd. Non-Executive Director
FAQs on Remus Pharmaceuticals Share Price
What is the share price of Remus Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Remus Pharmaceuticals is ₹897.35 as on Aug 14, 2026.
What kind of stock is Remus Pharmaceuticals?
The Remus Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Remus Pharmaceuticals?
The market cap of Remus Pharmaceuticals is ₹1,057.44 Cr as on Aug 14, 2026.
What are today's High and Low prices of Remus Pharmaceuticals?
Today’s highest and lowest price of Remus Pharmaceuticals are ₹917.95 and ₹892.00.
What are the 52 Week High and 52 Week Low of Remus Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Remus Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Remus Pharmaceuticals is ₹952.00 and 52-week low of Remus Pharmaceuticals is ₹580.00 as on Aug 14, 2026.
How has the Remus Pharmaceuticals performed historically in terms of returns?
The Remus Pharmaceuticals has shown returns of 2.09% over the past day, 25.0% for the past month, 24.45% over 3 months, 1.54% over 1 year, 15.95% across 3 years, and 31.92% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Remus Pharmaceuticals?
P/E ratio of and PB ratio of Remus Pharmaceuticals are 22.90 and 3.01 on Aug 14, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕